Pepscan

Pepscan is a leading provider of peptide-based products and services, catering primarily to life science researchers and pharmaceutical companies. The company specializes in constrained peptides and is the inventor of the constraining technology, which enhances the affinity and selectivity of peptides, making them comparable to antibodies in functionality. Pepscan's core offerings include custom peptide synthesis, epitope mapping, and the development of CLIPS peptides, a new generation of biotherapeutics. The company operates in the biotechnology and pharmaceutical markets, focusing on drug discovery collaborations and the development of high-quality cGMP peptides for clinical trials. Pepscan generates revenue through the sale of custom peptides, licensing of its proprietary technologies, and collaborative research agreements. The business model is built on providing specialized, high-value services that meet the stringent requirements of its clients in drug development and research.

Keywords: peptide synthesis, constrained peptides, drug discovery, biotherapeutics, CLIPS peptides, epitope mapping, cGMP peptides, life science research, pharmaceutical, biotechnology.